José Mejía Oneto, a physician scientist with training in orthopedic surgery and organic chemistry, is the founder and CEO of Shasqi, a clinical stage biotech company using its Click Activated Protodrugs Against Cancer (CAPAC TM) platform to maximize the efficacy of oncology therapies and enable patients to beat cancer without poisoning their bodies.
.svg)
